Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber
HealthTree Podcast for Multiple Myeloma
00:00
Treatment Success with Selenexar and Bortesumib in Multiple Myeloma Patients
The chapter showcases the positive outcomes of Selenexar and Bortesumib in patients with multiple myeloma, particularly in those who were previously not exposed to Bortesumib. A patient with 17-P disease who responded well to the Selenexar Bortesumib combination is now being considered for Carti treatment, highlighting the hope and efficacy of these treatments for high-risk individuals.
Transcript
Play full episode
